Basel Medical (BMGL) EBITDA Margin (2024)
Basel Medical's (BMGL) quarterly EBITDA Margin came in at 15.21% in Q4 2024.
Basel Medical (BMGL) EBITDA Margin (2024) Analysis & Trends
Basel Medical has disclosed EBITDA Margin across 1 years of filings, most recently posting 15.21% for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -2.96% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 24.14% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 14.11% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 3.76% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 8.99% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 11.19% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 4,926.74% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 15.04% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 8.45% |
| 10 | Basel Medical | 8.86 Mn | 6.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -15.21% |